NEW YORK, Nov. 20, 2020 /PRNewswire/ -- Longevity
Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a
publicly-traded special purpose acquisition company, announced
today that it has elected to extend the date by which it has to
consummate a business combination from November 30, 2020 to May
29, 2021 (the "Extension").
At a special meeting (the "Special Meeting") of shareholders
held on November 20, 2020, the
Company's shareholders approved an amendment to the Company's
charters to effect the Extension and subsequently, the Company
filed the amendment to its charters with the Registry of Corporate
Affairs in the British Virgin
Islands.
As a result, the Company now has until May 29, 2021 to consummate its proposed business
combination with 4D Pharma PLC ("4D") that it announced in its Form
8-K filed with the Securities and Exchange Commission on
October 22, 2020 (the "Merger"),
thereby allowing sufficient time for satisfaction of the remaining
conditions to the Merger, including 4D's filing of a
registration statement on Form F-4 (the "Registration Statement")
in order to allow 4D to apply to admit its American Depositary
Shares for trading on NASDAQ and the convening of a
shareholder meeting of both the Company's shareholders and 4D's
shareholders.
About LOAC
LOAC is a blank check company, also commonly referred to as a
Special Purpose Acquisition Company, or SPAC, formed for the
purpose of acquiring, engaging in a share exchange, share
reconstruction and amalgamation, purchasing all or substantially
all of the assets of, entering into contractual arrangements, or
engaging in any other similar business combination with one or more
businesses or entities. LOAC is contemplating a proposed business
combination with 4D Pharma PLC, a public limited company
incorporated under the laws of England and Wales pursuant to an agreement and plan of
merger dated October 21, 2020 as
disclosed in a Form 8-K filed with the Securities and Exchange
Commission on October 22, 2020. LOAC
is sponsored by Whale Management Corporation, a BVI business
company with limited liability.
Forward-Looking Statements
This press release and the exhibits hereto include
"forward-looking statements" within the meaning of the safe harbor
provisions of the U.S. Private Securities Litigation Reform Act of
1995 and within the meaning of Section 27a of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange Act of
1934, as amended. Any actual results may differ from expectations,
estimates and projections presented or implied and, consequently,
you should not rely on these forward-looking statements as
predictions of future events. Words such as "expect," "estimate,"
"project," "budget," "forecast," "anticipate," "intend," "plan,"
"may," "will," "could," "should," "believes," "predicts,"
"potential," "continue," and similar expressions are intended to
identify such forward-looking statements. These forward-looking
statements include, without limitation, LOAC's expectations with
respect to future performance, anticipated financial impacts of the
proposed business combination, approval of the business combination
transactions by security holders, the satisfaction of the closing
conditions to such transactions and the timing of the completion of
such transactions.
Contact:
Matthew Chen
Longevity Acquisition Corporation
+ (86) 21-60832028
mchen@lonacq.com
View original
content:http://www.prnewswire.com/news-releases/longevity-acquisition-corporation-announces-extension-of-deadline-to-complete-a-business-combination-301178217.html
SOURCE Longevity Acquisition Corporation